Status:
COMPLETED
Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines.
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Elective Spine Surgery Receiving Pre and/or Postoperative Pain Control With Opioids
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the safety, acceptability, and feasibility of a controlled taper off of opioids and/or benzodiazepines, with the use of behavioral health tele-health based ther...
Eligibility Criteria
Inclusion
- Preoperative benzodiazepines opioid dependence (daily use of opioids or benzodiazepines preoperatively) (Naive: No Meds 30 Days Prior to surgery,Opioid tolerant/dependant: Use of Meds on Most Days For 1 or more months prior to surgery)
- Subject willing to use Lucid Lane program to provide behavioral health support perioperative period up to 6 months post-op for tolerant opioid/benzo users
- Subject is willing to discuss Lucid Lane progress with the University of Texas Health Science Center(UTHealth) perioperative team and prescribing clinicians
- Subject is willing to sign a Lucid Lane Client Agreement
- Willing to sign an informed consent
Exclusion
- Serious mental illnesses including schizophrenia-spectrum disorders, severe bipolar disorder, and severe major depression.
- Active suicidal ideations
- Patients on methadone or buprenorphine for treatment of opioid use disorder (i.e. for treatment of addiction, and not for treatment of pain)
- Patient unwilling to use or not possessing access to a device that allows for video visits (e.g. a smartphone, tablet, or computer)
- Patients who are on palliative care
- Insufficient ability to use English to participate in the consent process, the intervention or study assessments.
- Insufficient ability to provide informed consent to participate
- If the patient misses more than 2 lucid lane sessions per week, the staff will be immediately notified by Lucid Lane.
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04787692
Start Date
August 7 2020
End Date
January 1 2022
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030